SK Bioscience-MSD contract on Ebola virus candidate
A signing ceremony for a contract manufacturing agreement under which SK Bioscience Co. will produce a next-generation Zaire Ebola virus candidate of Merck Sharp & Dohme (MSD), an American multinational pharmaceutical company, takes place in Seoul on May 4, 2023, in this photo provided by the South Korean drugmaker on May 8. From left are Sanat Chattopadhyay, an MSD executive vice president, South Korean Second Vice Health Minister Park Min-soo and SK Discovery Vice Chairman Choi Chang-won. (PHOTO NOT FOR SALE) (Yonhap)
(END)
(C) Yonhap News Agency. All Rights Reserved
